Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing

INTRODUCTION: Insulin icodec is a novel, long-acting insulin analog designed to cover basal insulin requirements with once-weekly subcutaneous administration. Here we describe the molecular engineering and the biological and pharmacological properties of insulin icodec. RESEARCH DESIGN AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, Erica, Pridal, Lone, Glendorf, Tine, Hansen, Bo Falk, Hubálek, František, Kjeldsen, Thomas, Kristensen, Niels Rode, Lützen, Anne, Lyby, Karsten, Madsen, Peter, Pedersen, Thomas Åskov, Ribel-Madsen, Rasmus, Stidsen, Carsten Enggaard, Haahr, Hanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Emerging Technologies, Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378355/
https://www.ncbi.nlm.nih.gov/pubmed/34413118
http://dx.doi.org/10.1136/bmjdrc-2021-002301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378355/
https://www.ncbi.nlm.nih.gov/pubmed/34413118
http://dx.doi.org/10.1136/bmjdrc-2021-002301

Ejemplares similares